BRAINTREE, Mass., Dec. 3, 2019 /PRNewswire/ -- Haemonetics
Corporation (NYSE: HAE), a global medical technology company
focused on delivering innovative hematology solutions to drive
better patient outcomes, announced the North American
commercial availability for the next generation of its market
leading SafeTrace Tx® Transfusion Management
Software, a blood bank information system (BBIS). Featuring a
contemporary new look, easy-to-use navigation and optimized user
experience, this latest software version helps elevate transfusion
safety, interoperability, workflow efficiency and continuity of
care.
"SafeTrace Tx is used by hundreds of hospitals to support safe,
efficient and effective blood bank operations," said Stew Strong,
President, Global Hospital at Haemonetics. "With our first customer
live on the next generation software, we are excited to build on
this momentum as interoperability and analytics continue to gain
importance in Hospital Information Systems."
SafeTrace Tx is a specialized transfusion management system used
in the blood bank to manage patient and blood product information
and to assist in determining blood product suitability for
patient transfusion. The software helps ensure patient transfusion
safety by using patented features to help guard against mistakes
and protect patients from transfusion errors. Designed with
input from experienced blood bankers, the next generation software
offers new and improved data visualizations that provide
interactive dashboards and analytics for operational, management
and quality reporting for transfusion services.
Blood transfusions are one of the most frequent procedures
performed in U.S. hospitals1. For more information on
SafeTrace Tx visit:
https://transfusionmanagement.haemonetics.com/
About Haemonetics
Haemonetics (NYSE: HAE) is a global
healthcare company dedicated to providing a suite of innovative
hematology products and solutions for customers, to help them
improve patient care and reduce the cost of healthcare. Our
technology addresses important medical markets: blood and plasma
component collection, the surgical suite and hospital transfusion
services. To learn more about Haemonetics, visit
www.haemonetics.com.
1
https://www.hcup-us.ahrq.gov/reports/statbriefs/sb165.jsp
Investor
Contact:
|
Media
Contact:
|
Olga Guyette,
Director-Investor Relations
|
Carla Burigatto,
VP-Communications
|
(781)
356-9763
|
(781)
348-7263
|
olga.guyette@haemonetics.com
|
carla.burigatto@haemonetics.com
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/haemonetics-releases-next-generation-safetrace-tx-transfusion-management-software-in-north-america-300968111.html
SOURCE Haemonetics Corporation